Table 2.
Clinical outcome comparisons between the baseline cohort (2011–2013) and the evaluation cohort (2014–2016)
| Baseline cohort 2011–2013 |
Evaluation cohort 2014–2016 |
|||
|---|---|---|---|---|
| n | % | n | % | |
| CABG | 184 | 128 | ||
| 120-day mortality | 1 | 0.5 | 0 | 0.0 |
| CVA | 1 | 0,5 | 0 | 0.0 |
| DSWI | 3 | 1.6 | 1 | 0.8 |
| Surgical re-exploration | 10 | 5.4 | 6 | 4.7 |
| PCI | 636 | 527 | ||
| 30-day mortality | 9 | 1.4 | 5 | 0.9 |
| Urgent CABG | 2 | 0.3 | 0 | 0.0 |
| MI | 3 | 0.5 | 5 | 1.0 |
| Coronary artery diseasea | 810 | 643 | ||
| Mortality | 10 | 1.2 | 5 | 0.8 |
| Complications | 17 | 2.1 | 11 | 1.8 |
| Event-free survival (short-term) | 780 | 96.7 | 603 | 97.4 |
a Treated with either CABG or PCI